ChatGPTを活用して業務のAI化を進めています。プロンプトエンジニアリングの専門家です！と、名乗れるレベルではありませんが、かなり色々使いこなしてきています。この１年、病気で失われた能力は、別な能力を発達させる、進化することで生き残っていこうと思います。
<><><>
<>
24/04/04
Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review
N Enomoto - Respiratory Investigation, 2024
… While idiopathic interstitial pneumonia (IIP) centering on idiopathic pulmonary fibrosis(IPF) is the most prevalent interstitial lung disease (ILD), especially in the older adult population, connective tissue disease (CTD)-related ILD is the second …
[PDF] Survival and Lung Function Changes in Hypersensitivity Pneumonitis According to Radiological Phenotypes Compared With Idiopathic Pulmonary Fibrosis
G Juliá-Serdá, J Navarro-Esteva, L Doreste-Salgado… - Cureus, 2024
… (HP), both fibrotic (f-HP) and nonfibrotic (nf-HP), and to compare them with those in patients with idiopathic pulmonary fibrosis (IPF). … In most cases, IPF was diagnosed based on HRCT findings. Results: We identified 84 patients: 46 with IPF …
- 特発性肺線維症と比較した放射線学的表現型に基づく過敏性肺炎における生存および肺機能の変化
Cura Personalis: Bringing Care to the Whole Person with Idiopathic Pulmonary Fibrosis
E Dixon-Johnson - 2024
… Idiopathic pulmonary fibrosis (IPF) is a life-limiting chronic interstitial lung disease with symptoms of cough, shortness of breath, fatigue, anxiety, and depression. Palliative care (PC) aims to treat such symptoms for seriously ill patients. … Using …
- Cura Personalis: 特発性肺線維症患者全体をケアする
[HTML] Bioinformatics-based dynamics of cuproptosis-related indicators in experimental silicosis
J Xia, C Wu, X Jin, M Ding, C Zhang, G Hou, C Hao… - … and Environmental Safety, 2024
… To test this hypothesis, we screened the genetic changes in patients with idiopathicfibrosis … We identified 9 cuproptosis-related genes among the differential genes in patients with IPF at … to the possibility of cuproptosis in the …
- 実験的珪肺症におけるキュプロトーシス関連指標のバイオインフォマティクスに基づく動態
[PDF] An overview of Interstitial Lung Disease for the Pulmonary medicine resident
VK Viswanathan - Medical Research Archives, 2024
… ILDs with unknown aetiology include the various idiopathic interstitial pneumonias and the rare forms of ILDs like Lymphangiomyomatosis (LAM) & the various vasculitis. Idiopathic interstitial pneumonias are further classified into …
- 呼吸器内科研修医のための間質性肺疾患の概要
Aging-associated Cyst Formation and Fibrosis
Y Tsuchiya, T Seki, H Nakano, M Tanaka, R Takahashi - Yakugaku zasshi: Journal of …, 2024
… Additionally, we provide a brief summary of the two currently approved anti-fibrotic drugs for idiopathic pulmonary fibrosis, nintedanib and pirfenidone, as well as their possibility of future expansion of application toward other fibrotic diseases. …
- 加齢に伴う嚢胞形成と線維化
The diagnostic efficiency and safety of transbronchial lung cryobiopsy using 1.1-mm cryoprobe in diagnosing interstitial lung disease
Y Bian, M Deng, Q Gao, G Zhou, R Tong, L Zhao, M Liu… - 2024
… TBLC is also included in clinical practice guidelines for hypersensitivity pneumonitis (7) and idiopathic pulmonary fibrosis (IPF) (8) as a … Only a small number of patients were diagnosed with IPF and nonspecific interstitial pneumonia …
- 間質性肺疾患の診断における 1.1 mm 凍結プローブを使用した経気管支肺凍結生検の診断効率と安全性
[HTML] Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis
S Arnold, AR Kitching, V Witko-Sarsat, T Wiech… - The Lancet Rheumatology, 2024
… About 5–10% of individuals diagnosed with idiopathic pulmonary fibrosis and usual interstitial pneumonia are MPO-… idiopathicpulmonary fibrosis after being ANCAnegative at the time of first evaluation. Finally, approximately 25% of …
- ミエロペルオキシダーゼ特異的抗好中球細胞質抗体関連血管炎
[HTML] 加齢による嚢胞形成と線維化
土屋勇一， 関崇生， 中野裕康， 田中稔， 髙橋良哉 - YAKUGAKU ZASSHI, 2024
… Additionally, we provide a brief summary of the two currently approved anti-fibrotic drugs for idiopathic pulmonary fibrosis, nintedanib and … しかし本邦で承認されている 抗線維化薬は,特発性肺線維症(idiopathic pulmonary fibrosis: IPF)に対するニンテダニブ …
- 加齢による嚢胞形成と線維化
24/04/02
[HTML] The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
SS Zamparelli, C Lombardi, C Candia, PR Iovine… - Journal of Clinical Medicine, 2024
… Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible fibrotic disease whose natural history is … and IPF in particular, this comprehensive approach remains underused and under-resourced. In this review, we will discuss the …
- 特発性肺線維症における呼吸リハビリテーションの有益な効果：最新文献のレビュー
Targeting reprogrammed metabolism as a therapeutic approach for respiratory diseases
PXL Gan, S Zhang, WSF Wong - Biochemical Pharmacology, 2024
… diseases such as asthma, idiopathicpulmonary fibrosis (IPF), and chronic … , IPF, and COPD, supports targeting metabolism as a therapeutic approach for respiratory diseases. Correspondingly, inhibiting glycolysis has largely attested effective …
- 呼吸器疾患の治療アプローチとして再プログラムされた代謝を標的とする
Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11
I Roger, P Montero, J Milara, J Cortijo - European Journal of Pharmacology, 2024
… Idiopathic pulmonary fibrosis (IPF) associated to pulmonary hypertension (PH) portends a poor … Serum and parenchyma levels of Interleukin 11 (IL-11) are elevated in IPF-PH patients and … Idiopathic pulmonaryfibrosis (IPF) is a disease …
- ピルフェニドンとニンテダニブは、IL-11 によって誘発される肺動脈内皮細胞と平滑筋細胞の変化を軽減します
24/03/31
[PDF] Investigation of the Mechanism of Action of Qingzaojiufei Decoction on Idiopathic Pulmonary Fibrosis Based on Network Pharmacology and Experimental Validation
C Mao, Y Du, K Niu, F Yang, C Bai, B Zhou, Y Niu - Natural Product Communications, 2024
… is effective for the treatment of idiopathicpulmonary fibrosis (IPF). In this study, we explored the anti-pulmonary fibrosis effect of QZJFD and … In total, 3875 disease action targets were related to IPF, with 308 common targets shared by drugs and …
- ネットワーク薬理学と実験的検証に基づく特発性肺線維症に対する青蔵九肥煎じ薬の作用機序の研究
[HTML] Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis
D Ishii, T Kawasaki, H Sato, K Tatsumi, T Imamoto… - International Journal of …, 2024
… Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive fibrosing interstitial pneumonia of … IPF remain unclear. This study explored the potential PBMC signature in patients with IPF and the effects of anti-fibrotic drugs on …
- 特発性肺線維症における末梢血単核球のトランスクリプトームに対する抗線維化薬の影響
Association Between Inhaled Corticosteroid and Incidence of Idiopathic Pulmonary Fibrosis: Nationwide Population based Study
H Lee, HY Yoon - 2024
… Idiopathic pulmonary fibrosis (IPF), one of the most prevalent forms of interstitial lung disease (ILD), is a chronic and progressive … , IPF results in substantial respiratory impairment and poor prognoses, with a median survival of 3–5 years post-diagnosis …
- 吸入コルチコステロイドと特発性肺線維症の発生率との関連性: 全国規模の人口ベースの研究
[PDF] Ginsenoside Rh4 alleviates idiopathic pulmonary fibrosis by enhancing the CXCL9–CXCR3 axis
L Yao, L Qu, J Deng, C Zhu, R Fu, M Jiang, D Fan - Food Frontiers
… ginsenoside Rh4 on idiopathic pulmonaryfibrosis (IPF): (a… IPF mice; (c) impact of ginsenoside Rh4 on mortality in IPF mice; (d) influence of ginsenoside Rh4 on hydroxyproline (HYP) content in the lungs of IPF mice; (e) effect of ginsenoside Rh4 …
- ジンセノサイド Rh4 は、CXCL9-CXCR3 軸を強化することで特発性肺線維症を軽減
[PDF] Defining the role of epithelial LKB1 in idiopathic pulmonary fibrosis
Z Xu - 2024
… Idiopathic pulmonary fibrosis (IPF), a form of this … in pulmonary fibrosis through paracrine signalling, thus fostering epithelial-mesenchymal transition (EMT). Autophagy, a cellular recycling process, is a potential treatment strategy in several …
- 特発性肺線維症における上皮LKB1の役割の定義
A Multi-dimensional Classifier to Support Lung Transplant Referral in Patients with Pulmonary Fibrosis
JV Pugashetti, JS Kim, MP Combs, SF Ma… - The Journal of Heart and …, 2024
… Lung transplantation remains the sole curative option for patients with idiopathic pulmonaryfibrosis (IPF), but donor organs remain scarce, and many eligible patients die prior to transplant. Tools to optimize the timing of transplant referral are urgently …
- 肺線維症患者における肺移植の紹介をサポートする多次元分類器
[HTML] Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice
A Dare, SD King, SY Chen - Scientific Reports, 2024
… Surfactant protein A (SPA) regulates macrophage function, strongly binds to lipids, and is implicated in renal and idiopathicpulmonary fibrosis (IPF). However, the role of SPA in lipid accumulation, inflammation, and hepatic fibrosis that characterize …
- 界面活性剤プロテインAはマウスの西洋食誘発性肝脂肪症と線維症を促進
<>
<><><>
特発性肺線維症( idiopathic pulmonary fibrosis (IPF) )関連の学術的情報収集してシェアしています。Google Scholar SearchのUpdateを定期的に掲載しています。GoogleのAIが一定の重み付けはしているとは思いますが、玉石混交です。
当面、毎週アラートの内容をアップしていこうと思います。
###
